HYFT
ImmunoPrecise Antibodies Ltd.
1.30$
-4.0%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Cash Flow
ImmunoPrecise Antibodies Ltd. (HYFT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2026), "Operating Cash Flow" came in at -12 million CAD. Tick rows to compare them in a chart.
All figures in millions of CAD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.0 | 0.3 | -0.7 | -3.4 | -3.2 | -1.4 | -0.6 | -9.9 | -20 | -4.2 | -6.4 | -12 | |
| 0.0 | 0.0 | 0.1 | 0.5 | 2.3 | 3.4 | 3.7 | 3.8 | 6.7 | 5.7 | 5.1 | 1.6 | |
| – | – | 0.2 | 1.2 | 1.1 | 0.7 | 2.7 | 3.1 | 1.9 | 1.5 | 0.4 | 1.3 | |
| 0.0 | 0.1 | 0.4 | -0.2 | 0.6 | -1.1 | -1.0 | 0.6 | -3.3 | 2.4 | 0.3 | -2.0 | |
| 0.0 | 0.0 | 0.5 | 0.3 | 0.6 | 0.6 | 1.4 | 1.3 | 1.5 | 1.4 | 0.8 | 0.4 | |
| 0.0 | -0.1 | -0.2 | -7.2 | -2.2 | -1.6 | -2.5 | -5.2 | -2.0 | -1.6 | -0.8 | 13 | |
| 0.2 | 0.1 | 0.1 | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | -1.0 | -1.3 | -1.3 | 2.7 | -0.8 | |
| 0.0 | -0.1 | 3.2 | 9.8 | 9.4 | 0.2 | 43 | 2.9 | -0.6 | 1.0 | 15 | 0.1 | |
| 0.0 | 0.1 | 2.2 | -0.8 | 3.7 | -2.8 | 39 | -12 | -22 | -4.8 | 7.2 | 0.8 | |
| -0.1 | 0.3 | -1.3 | -3.8 | -3.9 | -2.0 | -2.0 | -11 | -21 | -5.6 | -7.2 | -13 |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.